Literature DB >> 32867878

Interventions to improve antibiotic prescribing at hospital discharge: A systematic review.

Lindsay M Daniels1, David J Weber2,3.   

Abstract

A large proportion of antibiotic use associated with hospitalization occurs immediately after discharge, representing an important focus for antimicrobial stewardship programs. This review identified few studies evaluating the effect of interventions aimed at improving discharge antibiotic prescribing. Antimicrobial stewardship to improve postdischarge antibiotic prescribing is an unmet need warranting further study.

Year:  2020        PMID： 32867878     DOI： 10.1017/ice.2020.367

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  4 in total

Review 1.  Antibiotic Overuse and Stewardship at Hospital Discharge: The Reducing Overuse of Antibiotics at Discharge Home Framework.

Authors:  Valerie M Vaughn; Adam L Hersh; Emily S Spivak
Journal:  Clin Infect Dis       Date:  2022-05-03       Impact factor: 20.999

2.  ADD It Up: An Evaluation of Antibiotic Duration at Hospital Discharge at a Community Hospital.

Authors:  Morgan Conner; William H Harris; John P Bomkamp
Journal:  Open Forum Infect Dis       Date:  2021-07-24       Impact factor: 3.835

Review 3.  Mastitis Control and Intramammary Antimicrobial Stewardship in Ireland: Challenges and Opportunities.

Authors:  Simon J More; Catherine McAloon; Pablo Silva Boloña; Luke O'Grady; Frank O'Sullivan; Michelle McGrath; Willie Buckley; Kevin Downing; Patrick Kelly; Eoin G Ryan; Finola McCoy
Journal:  Front Vet Sci       Date:  2022-04-11

4.  A Statewide Collaborative Quality Initiative to Improve Antibiotic Duration and Outcomes in Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia.

Authors:  Valerie M Vaughn; Tejal N Gandhi; Timothy P Hofer; Lindsay A Petty; Anurag N Malani; Danielle Osterholzer; Lisa E Dumkow; David Ratz; Jennifer K Horowitz; Elizabeth S McLaughlin; Tawny Czilok; Scott A Flanders
Journal:  Clin Infect Dis       Date:  2022-08-31       Impact factor: 20.999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.